Medline Inc.
L10
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 129.00M | 182.00M | 322.00M | -- | 322.00M |
| Total Depreciation and Amortization | 254.00M | 261.00M | 253.00M | -- | 247.00M |
| Total Amortization of Deferred Charges | 11.00M | 14.00M | 15.00M | -- | 15.00M |
| Total Other Non-Cash Items | 179.00M | 54.00M | 45.00M | -- | 93.00M |
| Change in Net Operating Assets | -161.00M | -282.00M | 1.00M | -- | 5.00M |
| Cash from Operations | 412.00M | 229.00M | 636.00M | -- | 682.00M |
| Capital Expenditure | -96.00M | -138.00M | -101.00M | -- | -98.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | -- | 6.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -96.00M | -138.00M | -101.00M | -- | -92.00M |
| Total Debt Issued | -- | 0.00 | 7.57B | -- | 179.00M |
| Total Debt Repaid | -- | -4.09B | -7.59B | -- | -179.00M |
| Issuance of Common Stock | -- | 7.05B | -- | -- | -- |
| Repurchase of Common Stock | -- | -1.97B | -18.00M | -- | -9.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -96.00M | -119.00M | -- | -- |
| Other Financing Activities | -13.00M | -- | -- | -- | -- |
| Cash from Financing | -13.00M | 897.00M | -161.00M | -- | -9.00M |
| Foreign Exchange rate Adjustments | -7.00M | -1.00M | -3.00M | -- | 9.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 296.00M | 987.00M | 371.00M | -- | 590.00M |